Join leading neurologists, geneticists, and researchers from around the world for groundbreaking discussions on Neurofibromatosis Type 1, Type 2, and Schwannomatosis. Discover the latest advancements in diagnosis, treatment, and patient care.
Neurofibromatosis (NF) is a genetic disorder that causes tumors to form on nerve tissue. These tumors can develop anywhere in the nervous system.
Neurofibromatosis is a group of three conditions: NF1, NF2, and schwannomatosis. NF1 is the most common, affecting about 1 in 3,000 people worldwide. It's caused by mutations in the NF1 gene and is characterized by café-au-lait spots, freckling, and neurofibromas.
NF2 is less common (1 in 25,000) and involves tumors on the auditory nerves that can lead to hearing loss. Schwannomatosis is the rarest form and causes painful schwannomas on cranial, spinal, and peripheral nerves.
Neurofibromatosis symptoms vary widely between individuals, even within the same family. Early recognition leads to better management.
Café-au-lait spots, freckling in skin folds, and cutaneous neurofibromas (small, benign tumors on or under the skin).
Learning disabilities, headaches, seizures, and in NF2, hearing loss, tinnitus, and balance problems.
Lisch nodules (tiny hamartomas on the iris), vision problems, and in children, optic pathway gliomas.
Scoliosis, bowing of legs, sphenoid wing dysplasia, and increased fracture risk with poor healing.
High blood pressure, vasculopathy, and in some cases, congenital heart defects or pheochromocytoma.
Autosomal dominant inheritance pattern with 50% chance of passing NF to children when one parent is affected.
Learn from world-renowned experts in neurology, genetics, and NF research.
Director, NF Research Institute
Leading researcher in NF1 gene therapy and targeted treatments.
Pediatric Neurologist, Mayo Clinic
Specialist in childhood NF manifestations and early intervention.
Geneticist, Cambridge University
Expert in NF genetic counseling and mutation analysis.
Three days of comprehensive sessions, workshops, and networking opportunities.
Dr. Elena Rodriguez presents groundbreaking advances in NF gene therapy and personalized medicine approaches.
Comprehensive review of diagnostic criteria, imaging findings, and genetic testing for accurate NF typing.
Early intervention strategies, monitoring protocols, and family counseling for children with NF.
Advances in microsurgery, stereotactic radiosurgery, and minimally invasive techniques for tumor management.
Ethical considerations, prenatal testing options, and reproductive choices for individuals with NF.
Review of promising drug candidates, targeted therapies, and ongoing clinical research in NF treatment.
Expert discussion on integrated care models involving neurology, genetics, oncology, and supportive services.
Choose the registration package that best fits your needs. Early bird pricing ends July 31, 2024.
For students & early-career professionals
For healthcare providers & researchers
For senior specialists & institutional teams
Price: $499 per person
Complete your registration by filling out the form below.